---
id: FC-031
type: Flashcard
created: 2025-08-08 09:58:43.537955
tags:
- Flashcard
- question
- cardiovascular
topic: cardiovascular
answer: B
related_articles:
- title: Liraglutide Is Probably the Best Second Drug to Prevent Cardiovascular Events
    in Patients With Type 2 Diabetes Mellitus Who Take Metformin.
  path: 2023/2023-04-liraglutide-is-probably-the-best-second-drug-to-prevent-card.md
  similarity: 0.727
  link: '[[2023/2023-04-liraglutide-is-probably-the-best-second-drug-to-prevent-card|Liraglutide
    Is Probably the Best Second Drug to Prevent Cardiovascular Events in Patients
    With Type 2 Diabetes Mellitus Who Take Metformin.]]'
- title: 'Chronic Kidney Disease: Prevention, Diagnosis, and Treatment.'
  path: 2023/2023-12-chronic-kidney-disease-prevention-diagnosis-and-treatment.md
  similarity: 0.6
  link: '[[2023/2023-12-chronic-kidney-disease-prevention-diagnosis-and-treatment|Chronic
    Kidney Disease: Prevention, Diagnosis, and Treatment.]]'
- title: In Older Adults With Type 2 Diabetes, GLP-1 Receptor Agonists Decrease Major
    Adverse Cardiovascular Events; SGLT-2 Inhibitors Prevent Heart Failure Hospitalizations.
  path: 2025/2025-03-in-older-adults-with-type-2-diabetes-glp-1-receptor-agonists.md
  similarity: 0.583
  link: '[[2025/2025-03-in-older-adults-with-type-2-diabetes-glp-1-receptor-agonists|In
    Older Adults With Type 2 Diabetes, GLP-1 Receptor Agonists Decrease Major Adverse
    Cardiovascular Events; SGLT-2 Inhibitors Prevent Heart Failure Hospitalizations.]]'
- title: DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT-2 Inhibitors for People
    With Cardiovascular Disease.
  path: 2022/2022-07-dpp-4-inhibitors-glp-1-receptor-agonists-and-sglt-2-inhibito.md
  similarity: 0.545
  link: '[[2022/2022-07-dpp-4-inhibitors-glp-1-receptor-agonists-and-sglt-2-inhibito|DPP-4
    Inhibitors, GLP-1 Receptor Agonists, and SGLT-2 Inhibitors for People With Cardiovascular
    Disease.]]'
- title: 'Benign Prostatic Hyperplasia: Rapid Evidence Review.'
  path: 2023/2023-06-benign-prostatic-hyperplasia-rapid-evidence-review.md
  similarity: 0.529
  link: '[[2023/2023-06-benign-prostatic-hyperplasia-rapid-evidence-review|Benign
    Prostatic Hyperplasia: Rapid Evidence Review.]]'
topics:
- Cardiology
- Emergency Medicine
- Endocrinology
- Nephrology
- Orthopedics
- Pharmacology
related_articles_2023_2025:
- title: editorial cardiovascular disparities south asian people
  path: 2024/07/2024-07-editorial-cardiovascular-disparities-south-asian-people.md
  similarity: 0.307
  link: '[[2024/07/2024-07-editorial-cardiovascular-disparities-south-asian-people|editorial
    cardiovascular disparities south asian people]]'
last_updated: '2025-08-10T20:25:03.765798'
---

# Flashcard FC-031

## Question

Inpatientswith CKDstage4 orgreater,which one of the followinginterventionsismostappropriate? Continuationofmetforminregardlessofglycemicstatus. Continuationofanangiotensin-convertingenzymeinhibitororangiotensinreceptorblockerinpatients withhypertension. Administrationofcalcimimeticstolowerelevatedparathyroidlevels. Radiologicassessmentwithintravenousiodinatedcontrastmedia. BACK

## Answer

**B**

## Explanation

Discontinuationofrenin-angiotensin-aldosteronesystemblockadesinpatientswith CKDstage4 or5 is notroutinelyrecommended. Metforminisrecommendedastheinitialmedicationfordiabetesmellitus type2 inpatientswith CKDstages1 to3,butitiscontraindicatedinpatientswith CKDstages4 and5. Thereisalackofclearbenefitforcalcimimeticsonbonehealthinpatientswith CKDstages3 and4. Intravenousiodinatedcontrastmediashould beavoidedinpatientswithadvanced CKD. .

## References

- AAFPQuestion Bank Pythonsimplecapture.

